Results
|
1.
|
|
|
2.
|
Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agents. [electronic resource] by
- Noronha, Vanita
- Joshi, Amit
- Patil, Vijay Maruti
- Banavali, Shripad D
- Gupta, Sudeep
- Parikh, Purvish M
- Marfatia, Shalaka
- Punatar, Sachin
- More, Sucheta
- Goud, Supriya
- Nakti, Dipti
- Prabhash, Kumar
Producer: 20180522
In:
Asia-Pacific journal of clinical oncology vol. 14
Availability: No items available.
|
|
3.
|
Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer. [electronic resource] by
- Patil, Vijay
- Joshi, Amit
- Noronha, Vanita
- Agarwala, Vivek
- Chougule, Anuradha
- Kanan, Sadhana
- Bhattacharjee, Atanu
- Chandrasekharan, Arun
- Pande, Nikhil
- Simha, Vijai
- Goud, Supriya
- More, Sucheta
- Kumar, Rajiv
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: Oncotarget Oct 2019
In:
Oncotarget vol. 10
Availability: No items available.
|
|
4.
|
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation? [electronic resource] by
- Joshi, Amit
- Patil, Vijay
- Noronha, Vanita
- Chougule, Anuradha
- Bhattacharjee, Atanu
- Kumar, Rajiv
- Goud, Supriya
- More, Sucheta
- Ramaswamy, Anant
- Karpe, Ashay
- Pande, Nikhil
- Chandrasekharan, Arun
- Goel, Alok
- Talreja, Vikas
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: Lung India : official organ of Indian Chest Society
In:
Lung India : official organ of Indian Chest Society vol. 35
Availability: No items available.
|
|
5.
|
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapy. [electronic resource] by
- Noronha, Vanita
- Patil, Vijay
- Joshi, Amit
- Chougule, Anuradha
- Bhattacharjee, Atanu
- Kumar, Rajiv
- More, Sucheta
- Goud, Supriya
- Karpe, Ashay
- Ramaswamy, Anant
- Pande, Nikhil
- Chandrasekharan, Arun
- Goel, Alok
- Talreja, Vikas
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: Ecancermedicalscience 2017
In:
Ecancermedicalscience vol. 11
Availability: No items available.
|
|
6.
|
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation? [electronic resource] by
- Joshi, Amit
- Noronha, Vanita
- Patil, Vijay M
- Chougule, Anuradha
- Bhattacharjee, Atanu
- Kumar, Rajiv
- Goud, Supriya
- More, Sucheta
- Ramaswamy, Anant
- Karpe, Ashay
- Pande, Nikhil
- Chandrasekharan, Arun
- Goel, Alok
- Talreja, Vikas
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: Chemotherapy research and practice 2017
In:
Chemotherapy research and practice vol. 2017
Availability: No items available.
|
|
7.
|
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma. [electronic resource] by
- Patil, Vijay Maruti
- Noronha, Vanita
- Joshi, Amit
- Choughule, Anuradha Bharat
- Bhattacharjee, Atanu
- Kumar, Rajiv
- Goud, Supriya
- More, Sucheta
- Ramaswamy, Anant
- Karpe, Ashay
- Pande, Nikhil
- Chandrasekharan, Arun
- Goel, Alok
- Talreja, Vikas
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: ESMO open 2017
In:
ESMO open vol. 2
Availability: No items available.
|
|
8.
|
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in [electronic resource] by
- Noronha, Vanita
- Patil, Vijay Maruti
- Joshi, Amit
- Menon, Nandini
- Chougule, Anuradha
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Kumar, Rajiv
- More, Sucheta
- Goud, Supriya
- Kadam, Nandkumar
- Daware, Nilesh
- Bhattacharjee, Atanu
- Shah, Srushti
- Yadav, Akanksha
- Trivedi, Vaishakhi
- Behel, Vichitra
- Dutt, Amit
- Banavali, Shripad Dinanath
- Prabhash, Kumar
Producer: 20200625
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|
|
9.
|
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer. [electronic resource] by
- Patil, Vijay
- Noronha, Vanita
- Joshi, Amit
- Chougule, Anuradha
- Kannan, Sadhana
- Bhattacharjee, Atanu
- Goud, Supriya
- More, Sucheta
- Chandrasekharan, Arun
- Menon, Nandini
- Srinivas, Sujay
- Vallathol, Dilip Harindran
- Dsouza, Hollis
- Majumdar, Swaratika
- Das, Sudeep
- Zawar, Abhinav
- Khaddar, Satvik
- Kumar, Amit
- Singh, Gunjesh
- Kumar, Kanteti Aditya Pavan
- Ravind, Rahul
- Trivedi, Vaishakhi
- Behel, Vichitra
- Mahajan, Abhishek
- Janu, Amit
- Purandare, Nilendu
- Prabhash, Kumar
Publication details: EClinicalMedicine Mar 2019
In:
EClinicalMedicine vol. 9
Availability: No items available.
|